China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK)
Equity · Currency in HKD · Last updated Sep 28, 2023
Company Info
| ISIN | BMG210A71016 |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
Highlights
| Market Cap | HK$15.01B |
|---|---|
| EPS | HK$0.58 |
| PE Ratio | 6.13 |
| Revenue (TTM) | HK$10.34B |
| Gross Profit (TTM) | HK$5.25B |
| EBITDA (TTM) | HK$3.20B |
| Year Range | HK$3.18 - HK$5.24 |
| Target Price | HK$7.60 |
Income Statement
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
| TTM | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue | |||||
Total Revenue | 10.34B | 9.56B | 8.60B | 6.35B | 6.59B |
Cost Of Revenue | 3.78B | 3.61B | 3.35B | 2.32B | 2.55B |
Gross Profit | 6.56B | 5.95B | 5.25B | 4.04B | 4.04B |
| Operating Expenses | |||||
Selling General & Admin Expenses | 3.78B | 3.37B | 3.31B | 685.24M | 612.98M |
R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Operating Expenses | 0.00 | 6.88B | 6.66B | 4.48B | 5.20B |
| Income | |||||
Income Before Tax | 2.93B | 2.52B | 2.79B | 2.07B | 1.36B |
Operating Income | 3.12B | 2.70B | 2.76B | 1.87B | 1.39B |
EBIT | 0.00 | 0.00 | 2.18B | 1.87B | 1.39B |
Earnings From Continuing Operations | 0.00 | 2.10B | 2.41B | 1.78B | 1.13B |
Net Income | 2.40B | 2.08B | 2.40B | 1.79B | 1.15B |
Income Tax Expense | 0.00 | 0.00 | 380.80M | 292.37M | 230.49M |
Interest Expense | 567.32M | 13.75M | 92.96M | 115.42M | 146.50M |
Other Non Operating Income (Expenses) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Effect Of Accounting Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Recurring | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | -18.83M | -2.47M | 104.71M | 135.74M |
Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Values in HKD except per share items